1344698-60-7

Upstream product

• 225928-10-9 4-(bromoethynyl)benzoic acid methyl ester 
• 6746-94-7 Cyclopropylacetylene 
• 1344700-30-6 4-(4-cyclopropylbuta-1,3-diyn-1-yl)benzoic acid methyl ester 
• 1093193-97-5 4-(4-cyclopropylbuta-1,3-diyn-1-yl)benzoic acid 
• 1344700-32-8 1-(4-cyclopropylbuta-1,3-diyn-1-yl)-4-{[1-methoxy-3-(methylamino)-1,3-dioxopropan-2-yl](methyl)carbamoyl}benzene 
• 1344699-98-4 ({[1-methoxy-3-(methylamino)-1,3-dioxopropan-2-yl](methyl)amino}methyl)benzene 
• 1344700-00-0 N²-(t-butoxycarbonyl)-N,N²,O-trimethyl-3-oxoserinamide 

Relevant academic research and scientific papers

NOVEL HYDROXAMIC ACID DERIVATIVE

Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria. Provided is a hydroxamic acid derivative represented by the following general formula [1] or a pharmaceutically acceptable salt thereof: